1h Free Analyst Time
The head and neck cancer treatment market is forecasted to grow by USD 7.12 billion during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the head and neck cancer treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of head and neck cancers, growing geriatric population, and increasing number of cancer-related initiatives.
The head and neck cancer treatment market is segmented as below:
By Route Of Administration
- Injectable
- Oral
By Therapy
- Immunotherapy
- Targeted therapy
- Chemotherapy
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the head and neck cancer treatment market covers the following areas:
- Head and neck cancer treatment market sizing
- Head and neck cancer treatment market forecast
- Head and neck cancer treatment market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Market Segmentation by Therapy
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global head and neck cancer treatment market: Amgen Inc., AstraZeneca Plc, Ayala Pharmaceuticals Inc., Bristol Myers Squibb Co., Debiopharm International SA, Eli Lilly and Co., Incyte Corp., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements in diagnosis and treatment."
According to the report, one of the major drivers for this market is the increasing incidence of head and neck cancers.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc.
- AstraZeneca Plc
- Ayala Pharmaceuticals Inc.
- Bristol Myers Squibb Co.
- Debiopharm International SA
- Eli Lilly and Co.
- Incyte Corp.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
